Corebridge Financial’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,707
Closed -$19.9K 2892
2025
Q1
$19.9K Sell
16,707
-247
-1% -$394 ﹤0.01% 2906
2024
Q4
$34.9K Sell
16,954
-1,280
-7% -$2.98K ﹤0.01% 2901
2024
Q3
$46.1K Sell
18,234
-1,325,065
-99% -$4.32M ﹤0.01% 2879
2024
Q2
$5.74M Buy
+1,343,299
New +$8.64M 0.03% 655

Other funds holding GUTS

Corebridge Financial's GUTS Position: Q2 2025 in Review

Corebridge Financial sold out of Fractyl Health (GUTS) in Q2 2025, closing a stake of 16,707 shares — an estimated $19.9K sold.

Corebridge Financial first reported a position in GUTS in Q2 2024 and held it in 4 quarters. The position peaked at $5.74M in Q2 2024. 62 funds tracked by Wall St. Rank hold GUTS as of Q2 2025.

  • Corebridge Financial reported no remaining Fractyl Health position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 16,707 Fractyl Health shares in Q2 2025, an estimated $19.9K.
  • Corebridge Financial first reported a position in Fractyl Health in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Fractyl Health position peaked at $5.74M in Q2 2024.
  • 62 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.